Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
63
ENS Quote, Financials, Valuation and Earnings
Last price:
$179.30
Seasonality move
:
0.21%
Day range:
$175.86 - $180.99
52-week range:
$76.57 - $194.77
Dividend yield:
0.56%
P/E ratio:
22.18x
P/S ratio:
1.86x
P/B ratio:
3.49x
Volume:
646.9K
Avg. volume:
528K
1-year change:
75.55%
Market cap:
$6.6B
Revenue:
$3.6B
EPS (TTM):
$8.08
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | $3.4B | $3.7B | $3.6B | $3.6B | |
| Revenue Growth (YoY) | -3.56% | 12.74% | 10.46% | -3.42% | 1% | |
| Cost of Revenues | $2.2B | $2.6B | $2.9B | $2.6B | $2.5B | |
| Gross Profit | $746.8M | $742.6M | $841.9M | $996.8M | $1.1B | |
| Gross Profit Margin | 25.08% | 22.12% | 22.7% | 27.83% | 30.39% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $482.4M | $520.8M | $544.9M | $589.6M | $608.7M | |
| Other Inc / (Exp) | -$48.2M | -$17.4M | -$25.1M | -$51.2M | -$26.1M | |
| Operating Expenses | $482.2M | $520.6M | $544.8M | $589.3M | $608.4M | |
| Operating Income | $264.7M | $222M | $297.1M | $407.5M | $490.9M | |
| Net Interest Expenses | $40.7M | $37.8M | $64.8M | $56.9M | $60.5M | |
| EBT. Incl. Unusual Items | $170.1M | $173.9M | $210.6M | $292.2M | $406.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $26.8M | $30M | $34.8M | $23.1M | $42.8M | |
| Net Income to Company | $143.4M | $143.9M | $175.8M | $269.1M | $363.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $143.4M | $143.9M | $175.8M | $269.1M | $363.7M | |
| Basic EPS (Cont. Ops) | $3.37 | $3.42 | $4.31 | $6.62 | $9.15 | |
| Diluted EPS (Cont. Ops) | $3.32 | $3.36 | $4.25 | $6.50 | $8.99 | |
| Weighted Average Basic Share | $42.5M | $42.1M | $40.8M | $40.7M | $39.8M | |
| Weighted Average Diluted Share | $43.2M | $42.8M | $41.3M | $41.4M | $40.4M | |
| EBITDA | $358.7M | $317.9M | $388.3M | $499.5M | $591.8M | |
| EBIT | $264.7M | $222M | $297.1M | $407.5M | $490.9M | |
| Revenue (Reported) | $3B | $3.4B | $3.7B | $3.6B | $3.6B | |
| Operating Income (Reported) | $264.7M | $222M | $297.1M | $407.5M | $490.9M | |
| Operating Income (Adjusted) | $264.7M | $222M | $297.1M | $407.5M | $490.9M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $844M | $920.2M | $861.5M | $906.2M | $919.1M | |
| Revenue Growth (YoY) | 12.37% | 9.03% | -6.38% | 5.18% | 1.43% | |
| Cost of Revenues | $665.2M | $705M | $598.6M | $604.5M | $640.9M | |
| Gross Profit | $178.8M | $215.2M | $263M | $301.7M | $278.2M | |
| Gross Profit Margin | 21.18% | 23.39% | 30.53% | 33.29% | 30.27% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $130.7M | $134.3M | $144M | $154.3M | $147.8M | |
| Other Inc / (Exp) | -$1.1M | -$4M | -$14.3M | -$2.3M | -- | |
| Operating Expenses | $130.6M | $134.3M | $144M | $154.3M | $147.8M | |
| Operating Income | $48.1M | $81M | $119M | $147.4M | $130.4M | |
| Net Interest Expenses | $10.4M | $18.3M | $13.3M | $17.8M | $18.5M | |
| EBT. Incl. Unusual Items | $42.8M | $57.8M | $78.7M | $126.7M | $106.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.6M | $13.4M | $2.5M | $11.9M | $15.8M | |
| Net Income to Company | $36.3M | $44.4M | $76.2M | $114.8M | $90.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $36.3M | $44.4M | $76.2M | $114.8M | $90.4M | |
| Basic EPS (Cont. Ops) | $0.87 | $1.09 | $1.88 | $2.92 | $2.45 | |
| Diluted EPS (Cont. Ops) | $0.85 | $1.08 | $1.86 | $2.88 | $2.40 | |
| Weighted Average Basic Share | $41.9M | $40.8M | $40.5M | $39.3M | $36.9M | |
| Weighted Average Diluted Share | $42.5M | $41.3M | $41M | $39.9M | $37.7M | |
| EBITDA | $72.1M | $103.5M | $142.1M | $173M | $160.1M | |
| EBIT | $48.1M | $81M | $119M | $147.4M | $130.4M | |
| Revenue (Reported) | $844M | $920.2M | $861.5M | $906.2M | $919.1M | |
| Operating Income (Reported) | $48.1M | $81M | $119M | $147.4M | $130.4M | |
| Operating Income (Adjusted) | $48.1M | $81M | $119M | $147.4M | $130.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.3B | $3.6B | $3.7B | $3.6B | $3.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.5B | $2.8B | $2.7B | $2.5B | $2.6B | |
| Gross Profit | $739.4M | $792.2M | $986.9M | $1B | $1.1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $505.5M | $539.1M | $578.4M | $603.3M | $635.4M | |
| Other Inc / (Exp) | -$31.5M | -$21.9M | -$40.7M | -$33.9M | -- | |
| Operating Expenses | $505.2M | $538.9M | $578.4M | $603.3M | $635.4M | |
| Operating Income | $234.2M | $253.3M | $408.5M | $442.9M | $484.4M | |
| Net Interest Expenses | $40M | $59.9M | $58M | $59.9M | $66.9M | |
| EBT. Incl. Unusual Items | $178.3M | $173.8M | $301.4M | $356.8M | $364.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $28.6M | $35.8M | $27.3M | $28.7M | $51.9M | |
| Net Income to Company | $149.7M | $138M | $274.1M | $328.1M | $312.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $149.7M | $138M | $274.1M | $328.1M | $312.8M | |
| Basic EPS (Cont. Ops) | $3.52 | $3.37 | $6.72 | $8.22 | $8.21 | |
| Diluted EPS (Cont. Ops) | $3.46 | $3.33 | $6.61 | $8.08 | $8.08 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $330.4M | $345.9M | $499M | $541M | $595.5M | |
| EBIT | $234.2M | $253.3M | $408.5M | $442.9M | $484.4M | |
| Revenue (Reported) | $3.3B | $3.6B | $3.7B | $3.6B | $3.7B | |
| Operating Income (Reported) | $234.2M | $253.3M | $408.5M | $442.9M | $484.4M | |
| Operating Income (Adjusted) | $234.2M | $253.3M | $408.5M | $442.9M | $484.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.7B | $2.7B | $2.6B | $2.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.9B | $2.1B | $1.9B | $1.9B | $2B | |
| Gross Profit | $542.3M | $597.1M | $742.1M | $791.6M | $811.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $380.5M | $398.8M | $432.3M | $446M | $472.7M | |
| Other Inc / (Exp) | -$11.5M | -$15.9M | -$31.5M | -$14.2M | -$15.4M | |
| Operating Expenses | $380.3M | $398.7M | $432.3M | $446M | $472.7M | |
| Operating Income | $162M | $198.4M | $309.8M | $345.7M | $339.2M | |
| Net Interest Expenses | $30.2M | $49M | $42.1M | $45.1M | $51.4M | |
| EBT. Incl. Unusual Items | $135M | $134.9M | $225.6M | $290.2M | $248.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $19.2M | $25M | $17.4M | $23M | $32M | |
| Net Income to Company | $115.8M | $109.9M | $208.2M | $267.2M | $216.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $115.8M | $109.9M | $208.2M | $267.2M | $216.3M | |
| Basic EPS (Cont. Ops) | $2.73 | $2.69 | $5.11 | $6.71 | $5.76 | |
| Diluted EPS (Cont. Ops) | $2.69 | $2.66 | $5.02 | $6.60 | $5.66 | |
| Weighted Average Basic Share | $127.2M | $122.4M | $122.3M | $119.7M | $113.1M | |
| Weighted Average Diluted Share | $129.3M | $123.8M | $124.4M | $121.8M | $114.9M | |
| EBITDA | $234.3M | $267.4M | $378.1M | $420.1M | $423.8M | |
| EBIT | $162M | $198.4M | $309.8M | $345.7M | $339.2M | |
| Revenue (Reported) | $2.5B | $2.7B | $2.7B | $2.6B | $2.8B | |
| Operating Income (Reported) | $162M | $198.4M | $309.8M | $345.7M | $339.2M | |
| Operating Income (Adjusted) | $162M | $198.4M | $309.8M | $345.7M | $339.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $451.8M | $402.5M | $346.7M | $333.3M | $343.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $603.6M | $719.4M | $637.8M | $580.1M | $669.7M | |
| Inventory | $518.2M | $715.7M | $797.8M | $697.7M | $740M | |
| Prepaid Expenses | $31.8M | $32.7M | $22.9M | $114.4M | $268.2M | |
| Other Current Assets | $28.5M | $46.2M | $35.1M | $53.1M | $62.1M | |
| Total Current Assets | $1.7B | $2B | $1.9B | $1.8B | $2.1B | |
| Property Plant And Equipment | $559.2M | $574.3M | $598.5M | $608.9M | $676.1M | |
| Long-Term Investments | $5.4M | $3.6M | $2.5M | $2.7M | $5K | |
| Goodwill | $705.6M | $700.6M | $676.7M | $682.9M | $721.1M | |
| Other Intangibles | $430.9M | $396.2M | $360.4M | $319.4M | $375.4M | |
| Other Long-Term Assets | $72.7M | $82.9M | $121.2M | $98.7M | $117.7M | |
| Total Assets | $3.5B | $3.7B | $3.6B | $3.5B | $4B | |
| Accounts Payable | $323.9M | $393.1M | $378.6M | $369.5M | $405.7M | |
| Accrued Expenses | $234.3M | $202.1M | $205.4M | $216.2M | $224.6M | |
| Current Portion Of Long-Term Debt | $34.2M | $55.1M | $30.6M | $30.4M | $28.5M | |
| Current Portion Of Capital Lease Obligations | $22M | $20.3M | $21.3M | $19.5M | $22.6M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $677M | $738.1M | $718.3M | $723.9M | $775.1M | |
| Long-Term Debt | $1B | $1.3B | $1.1B | $864.3M | $1.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.9B | $2.2B | $2B | $1.7B | $2.1B | |
| Common Stock | $555K | $557K | $560K | $564K | $568K | |
| Other Common Equity Adj | -$115.9M | -$143.5M | -$183.5M | -$204.9M | -$247.5M | |
| Common Equity | $1.5B | $1.5B | $1.6B | $1.8B | $1.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $3.8M | $3.9M | $3.6M | $3.4M | $3.4M | |
| Total Equity | $1.5B | $1.5B | $1.6B | $1.8B | $1.9B | |
| Total Liabilities and Equity | $3.5B | $3.7B | $3.6B | $3.5B | $4B | |
| Cash and Short Terms | $451.8M | $402.5M | $346.7M | $333.3M | $343.1M | |
| Total Debt | $1B | $1.3B | $1.1B | $864.5M | $1.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $397.1M | $298.1M | $332.7M | $463.2M | $450.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $636M | $581.8M | $498.5M | $545.2M | $474.7M | |
| Inventory | $671.4M | $835.2M | $755.2M | $753.4M | $795.4M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $138.9M | $155.2M | $185.9M | $411.2M | -- | |
| Total Current Assets | $1.8B | $1.9B | $1.8B | $2.2B | $2.1B | |
| Property Plant And Equipment | $565.6M | $574.8M | $523.6M | $583.5M | $598.6M | |
| Long-Term Investments | $3.6M | $2.5M | $2M | $1.2M | -$389K | |
| Goodwill | $700.8M | $673.7M | $691.2M | $715.6M | -- | |
| Other Intangibles | $405.1M | $367.7M | $335M | $384.5M | -- | |
| Other Long-Term Assets | $74.5M | $103.3M | $127.3M | $119.1M | -- | |
| Total Assets | $3.6B | $3.6B | $3.5B | $4B | $4B | |
| Accounts Payable | $317.6M | $345.3M | $342.1M | $351.2M | $336.5M | |
| Accrued Expenses | $271M | $292.7M | $289.9M | $329.7M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $622.1M | $670M | $662.9M | $710.4M | $776.1M | |
| Long-Term Debt | $1.2B | $1.2B | $880.8M | $1.3B | $1.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.1B | $2B | $1.8B | $2.2B | $2.2B | |
| Common Stock | $557K | $560K | $563K | $567K | $574K | |
| Other Common Equity Adj | -$141M | -$186.1M | -$182.1M | -$261.8M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $3.9M | $3.6M | $3.5M | $3.4M | $3.5M | |
| Total Equity | $1.5B | $1.5B | $1.7B | $1.8B | $1.9B | |
| Total Liabilities and Equity | $3.6B | $3.6B | $3.5B | $4B | $4B | |
| Cash and Short Terms | $397.1M | $298.1M | $332.7M | $463.2M | $450.1M | |
| Total Debt | $1.2B | $1.2B | $880.8M | $1.3B | $1.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $143.4M | $143.9M | $175.8M | $269.1M | $363.7M | |
| Depreciation & Amoritzation | $94.1M | $95.9M | $91.2M | $92M | $100.9M | |
| Stock-Based Compensation | $19.8M | $24.3M | $26.4M | $30.6M | $27.8M | |
| Change in Accounts Receivable | $8.7M | -$129M | $67.6M | $108.6M | -$81.8M | |
| Change in Inventories | $24.2M | -$212.8M | -$96.4M | $75.6M | $1.3M | |
| Cash From Operations | $358.4M | -$65.6M | $279.9M | $457M | $260.3M | |
| Capital Expenditures | $70M | $74M | $88.8M | $86.4M | $121M | |
| Cash Acquisitions | -- | -- | -- | $8.3M | $206.4M | |
| Cash From Investing | -$65M | -$69.2M | -$44.8M | -$92.5M | -$336.4M | |
| Dividends Paid (Ex Special Dividend) | $29.8M | $29.4M | $28.5M | $34.5M | $37.5M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $102.7M | $524.2M | $611.6M | $483.7M | $650.5M | |
| Long-Term Debt Repaid | -$249.6M | -$249.8M | -$805.7M | -$721.4M | -$370M | |
| Repurchase of Common Stock | -- | $156.4M | $22.9M | $95.7M | $154M | |
| Other Financing Activities | -$5.2M | -$12.1M | -$7.6M | -$13.2M | -$8M | |
| Cash From Financing | -$188.7M | $98.4M | -$270.5M | -$370.6M | $90.3M | |
| Beginning Cash (CF) | $451.8M | $402.5M | $346.7M | $333.3M | $343.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $124.8M | -$49.3M | -$55.8M | -$13.3M | $9.8M | |
| Ending Cash (CF) | $596.9M | $340.2M | $270.3M | $312.7M | $348.6M | |
| Levered Free Cash Flow | $288.4M | -$139.6M | $191.2M | $370.6M | $139.3M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $36.3M | $44.4M | $76.2M | $114.8M | $90.4M | |
| Depreciation & Amoritzation | $24M | $22.6M | $23.1M | $25.6M | $29.7M | |
| Stock-Based Compensation | $6.4M | $6.9M | $9.8M | $8.1M | $7.5M | |
| Change in Accounts Receivable | -$56.2M | $141.8M | $46.1M | -$14.9M | $97.1M | |
| Change in Inventories | -$38.3M | $2.4M | $16.9M | -$7.2M | $10.6M | |
| Cash From Operations | -$12.5M | $206.1M | $134.5M | $81.1M | $184.6M | |
| Capital Expenditures | $17.7M | $17.9M | $23.2M | $24.3M | $13.3M | |
| Cash Acquisitions | -- | -- | -- | $748K | $6K | |
| Cash From Investing | -$16.4M | -$17.8M | -$23.1M | -$25M | -$13.3M | |
| Dividends Paid (Ex Special Dividend) | $7.3M | $7.1M | $9.1M | $9.5M | $9.6M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $146.9M | $47M | $10M | $174.4M | -- | |
| Long-Term Debt Repaid | -$34.4M | -$259.9M | -$81.8M | -$103.4M | -- | |
| Repurchase of Common Stock | $83M | -- | $35M | $38.7M | $83.6M | |
| Other Financing Activities | $94K | $146K | -$1.9M | $750K | -- | |
| Cash From Financing | $22.4M | -$201.9M | -$117.8M | $23.6M | -$113.2M | |
| Beginning Cash (CF) | $397.1M | $298.1M | $332.7M | $463.2M | $450.1M | |
| Foreign Exchange Rate Adjustment | -$4M | $17.2M | $11.3M | -$24.4M | $3.4M | |
| Additions / Reductions | -$10.4M | $3.7M | $5M | $55.2M | $61.5M | |
| Ending Cash (CF) | $382.6M | $318.9M | $349M | $494M | $515M | |
| Levered Free Cash Flow | -$30.2M | $188.3M | $111.4M | $56.8M | $171.3M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $149.7M | $138M | $274.1M | $328.1M | $312.8M | |
| Depreciation & Amoritzation | $96.2M | $92.6M | $90.5M | $98.1M | $111.1M | |
| Stock-Based Compensation | $18.7M | $27.2M | $30.5M | $28M | $37M | |
| Change in Accounts Receivable | -$102.6M | $34.7M | $83.7M | -$55.1M | $83.2M | |
| Change in Inventories | -$167.6M | -$185M | $66.9M | $28.7M | -$17.2M | |
| Cash From Operations | $8.2M | $148.3M | $464.3M | $261.9M | $538.8M | |
| Capital Expenditures | $68.6M | $79.2M | $90.3M | $118.2M | $97.5M | |
| Cash Acquisitions | -- | -- | $8.3M | $206M | $13M | |
| Cash From Investing | -$63.9M | -$35.3M | -$96.4M | -$334.8M | -$104.6M | |
| Dividends Paid (Ex Special Dividend) | $29.7M | $28.6M | $32.6M | $37.1M | $38M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $437.5M | $390.5M | $503M | $952.1M | -- | |
| Long-Term Debt Repaid | -$290.6M | -$492.3M | -$708.7M | -$554.3M | -- | |
| Repurchase of Common Stock | $114.5M | $64.7M | $82.3M | $127.3M | $341.4M | |
| Other Financing Activities | -$12.1M | -$7.3M | -$9.5M | -$12.4M | -- | |
| Cash From Financing | -$19.8M | -$180.7M | -$338.9M | $229.5M | -$480M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$91.6M | -$99M | $34.6M | $130.5M | -$13.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$60.4M | $69.1M | $374.1M | $143.7M | $441.3M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $115.8M | $109.9M | $208.2M | $267.2M | $216.3M | |
| Depreciation & Amoritzation | $72.3M | $69M | $68.3M | $74.4M | $84.6M | |
| Stock-Based Compensation | $15.8M | $18.8M | $22.9M | $20.3M | $29.5M | |
| Change in Accounts Receivable | -$40.3M | $123.4M | $139.5M | -$24.2M | $140.7M | |
| Change in Inventories | -$163.7M | -$135.9M | $27.4M | -$19.6M | -$38.1M | |
| Cash From Operations | -$78M | $135.8M | $320.2M | $125.1M | $403.6M | |
| Capital Expenditures | $52.4M | $57.5M | $59M | $90.8M | $67.2M | |
| Cash Acquisitions | -- | -- | $8.3M | $206M | $12.7M | |
| Cash From Investing | -$47.7M | -$13.7M | -$65.2M | -$307.5M | -$75.7M | |
| Dividends Paid (Ex Special Dividend) | $22.2M | $21.4M | $25.4M | $28.1M | $28.6M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $424.8M | $291.1M | $182.5M | $651M | $231.7M | |
| Long-Term Debt Repaid | -$201.5M | -$444M | -$347.1M | -$180M | -$46.9M | |
| Repurchase of Common Stock | $114.5M | $22.9M | $82.3M | $113.9M | $301.4M | |
| Other Financing Activities | -$11.5M | -$6.6M | -$8.6M | -$7.8M | $314K | |
| Cash From Financing | $76.3M | -$202.8M | -$271.2M | $328.9M | -$241.4M | |
| Beginning Cash (CF) | $1.2B | $975.7M | $918.8M | $1.2B | $1.2B | |
| Foreign Exchange Rate Adjustment | -$5.4M | -$23.8M | $2.3M | -$16.6M | $20.5M | |
| Additions / Reductions | -$54.7M | -$104.4M | -$14M | $129.8M | $107M | |
| Ending Cash (CF) | $1.2B | $847.6M | $907.1M | $1.3B | $1.3B | |
| Levered Free Cash Flow | -$130.4M | $78.3M | $261.2M | $34.3M | $336.4M | |
Get ENS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ENS
Sector
P/E ratio
22.18x
20.17x
PEG ratio
1.02x
0.18x
P/B ratio
3.49x
1.80x
Price / LTM sales
1.86x
0.87x
Growth Metrics
ENS
Sector
Revenue growth
1.43%
4.5%
Earnings growth
-16.56%
2.91%
Revenue (5-year growth)
3.22%
4.63%
Earnings forecast
$2.72
$0.33
Profitability
ENS
Sector
Profitability FY 2024
$1.1B
$234.7M
Return on invested capital
10.03%
4.57%
Return on assets
7.73%
3.16%
Return on equity
16.65%
8.11%
Earnings Date
Last Earnings Date
Feb
4
Next Earnings Date
May
20
Estimated Next Earnings Date
May
6
Balance Sheet
ENS
Sector
Total cash
$450.1M
$137.1M
Short term investments
--
$31.1M
Total assets
$4B
$1.4B
Long term debt
$1.1B
$44.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
58
TPH alert for Feb 14
Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.
Sell
20
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
